grouping the patients of the ISUP 1 and 2 scores, BRFS was no different whatever the lymphadenectomy status (p[0,75) (Figure 2) . In multivariate analysis, high PSA, ISUP score !3 on biopsy, pT3a or pT3b stage on operative specimen, and positive surgical margins were risk factors for biochemical recurrence.
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CONCLUSIONS METHODS: This international, observational and prospective study was performed from September 2017 to July 2018. The HFMEA was used to identify and evaluate hazardous stages of Urethroplasty to develop urethroplasty tools. Hazard scores were calculated for the included steps of urethroplasty. Content validation was performed by 13 expert surgeons and multidisciplinary teams from tertiary centres (Hong Kong, Italy, UK, Pakistan).
RESULTS: The HFMEA process resulted in an internationally validated UTATs. Hazard scores greater or equal to 4 and single-point weaknesses were included to implement actions and outcome measures. Content validation was achieved by circulating the process map, hazard analysis table and developed tools internationally. Changes were implemented based on the feedback until a consensus was reached between surgeons. Content validated single stage Dorsal and Ventral Onlay Buccal Mucosa Graft (BMG) Bulbar UTATs both contained 5 phases, 10 processes and 23 sub-processes. The 2 stage UTAT contained 8 phases, 13 processes and 24 sub-processes.
CONCLUSIONS: The UTATs offer comprehensive validated training tools developed via a detailed HFMEA protocol. This may be utilised to standardise the training and assessment of urology trainees.
